Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS23P9 (ribosomal protein S23 pseudogene 9) is a human pseudogene located at chromosome 1q23.3 that is homologous to the functional ribosomal protein S23 (RPS23) gene but contains sequence changes or truncations that prevent it from encoding a functional protein[2][4][8][12]. Pseudogenes like RPS23P9 may arise through duplication or retrotransposition but typically lack protein-coding capacity and are generally not associated with cellular functions, disease mechanisms, therapeutic targeting, or clinical biomarkers. There is no evidence that RPS23P9 produces a protein or participates in ribosomal function, making it ineligible as a canonical drug or therapeutic target[3][4][8][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S23 pseudogene 9 (RPS23P9).